Data on colorectal cancer (CRC) in HIV-positive patients are limited. The study objective was to investigate and compare clinical presentation and outcome between HIV-positive and HIV-negative CRC patients.Between September 1985 and November 2003 we identified 27 cases of HIV-positive CRC patients from the cancer registry database - Italian Cooperative Group AIDS and Tumours (GICAT); the clinical presentation/outcome information was retrieved. Each HIV-positive patient from our institution was randomly matched (ratio 1:2) with HIV-negative patients (54 controls) based on age, sex, and year of diagnosis in the same time period. Differences in clinical presentation, treatment, and overall survival were assessed.Of 1130 HIV-negative CRC patients, 54 were identified and matched with 27 HIV-positive patients. Compared with the HIV-negative patients, the HIV-positive patients had a higher risk of lower performance status (PS: > or =2) (odds ratio (OR) = 14.4; 95\% confidence interval (CI): 3.6-57.7), a higher risk of unfavorable Dukes' stage (D) (OR = 4.9; 95\% CI: 1.8-13.5), and a higher risk of poor grading (G3-G4) (OR = 5.0; 95\% CI: 1.9-13.4). Median overall follow-up was 27 months (range: 2-212). At multivariate analysis, the only characteristics that significantly reduced the survival of the CRC patients were: HIV-positive status (hazard ratio (HR): 2.4; 95\% CI: 1.1-5.2) and Dukes' stage D (HR: 3.7; 95\% CI: 1.9-7.1).Our data show that HIV-positive CRC patients compared to HIV-negative patients have a poorer PS, an unfavorable Dukes' stage, higher grading and shorter survival.

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: A clinical case-control study / M., Berretta; A., Cappellani; DI BENEDETTO, Fabrizio; A., Lleshi; R., Talamini; V., Canzonieri; E., Zanet; A., Bearz; G., Nasti; T., Lacchin; S., Berretta; R., Fisichella; L., Balestreri; A., Torresin; I., Izzi; P., Ortolani; U., Tirelli. - In: ONKOLOGIE. - ISSN 0378-584X. - ELETTRONICO. - 32:6(2009), pp. 319-324. [10.1159/000215719]

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: A clinical case-control study

DI BENEDETTO, Fabrizio;
2009

Abstract

Data on colorectal cancer (CRC) in HIV-positive patients are limited. The study objective was to investigate and compare clinical presentation and outcome between HIV-positive and HIV-negative CRC patients.Between September 1985 and November 2003 we identified 27 cases of HIV-positive CRC patients from the cancer registry database - Italian Cooperative Group AIDS and Tumours (GICAT); the clinical presentation/outcome information was retrieved. Each HIV-positive patient from our institution was randomly matched (ratio 1:2) with HIV-negative patients (54 controls) based on age, sex, and year of diagnosis in the same time period. Differences in clinical presentation, treatment, and overall survival were assessed.Of 1130 HIV-negative CRC patients, 54 were identified and matched with 27 HIV-positive patients. Compared with the HIV-negative patients, the HIV-positive patients had a higher risk of lower performance status (PS: > or =2) (odds ratio (OR) = 14.4; 95\% confidence interval (CI): 3.6-57.7), a higher risk of unfavorable Dukes' stage (D) (OR = 4.9; 95\% CI: 1.8-13.5), and a higher risk of poor grading (G3-G4) (OR = 5.0; 95\% CI: 1.9-13.4). Median overall follow-up was 27 months (range: 2-212). At multivariate analysis, the only characteristics that significantly reduced the survival of the CRC patients were: HIV-positive status (hazard ratio (HR): 2.4; 95\% CI: 1.1-5.2) and Dukes' stage D (HR: 3.7; 95\% CI: 1.9-7.1).Our data show that HIV-positive CRC patients compared to HIV-negative patients have a poorer PS, an unfavorable Dukes' stage, higher grading and shorter survival.
2009
32
6
319
324
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: A clinical case-control study / M., Berretta; A., Cappellani; DI BENEDETTO, Fabrizio; A., Lleshi; R., Talamini; V., Canzonieri; E., Zanet; A., Bearz; G., Nasti; T., Lacchin; S., Berretta; R., Fisichella; L., Balestreri; A., Torresin; I., Izzi; P., Ortolani; U., Tirelli. - In: ONKOLOGIE. - ISSN 0378-584X. - ELETTRONICO. - 32:6(2009), pp. 319-324. [10.1159/000215719]
M., Berretta; A., Cappellani; DI BENEDETTO, Fabrizio; A., Lleshi; R., Talamini; V., Canzonieri; E., Zanet; A., Bearz; G., Nasti; T., Lacchin; S., Berretta; R., Fisichella; L., Balestreri; A., Torresin; I., Izzi; P., Ortolani; U., Tirelli
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/860216
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 52
social impact